S1938 HCV-RNA Status At Week 12 of Treatment with Peginterferon Alfa-2a/RBV Predicts SVR in Patients with Prior Non-Response to Pegylated Interferon Alfa-2b/RBV: Results from Repeat Study

Autor:	Antonio Olveira, Pietro Andreone, B. Freilich, Greg Hooper, Carlos E. Brandao-Mello, Diethelm Messinger, K. Rajender Reddy, M. Popescu, Gerlinde Teuber, Patrick Marcellin, Adrian M. Di Bisceglie, Donald M. Jensen, Antonio Craxì
Rok vydání:	2008
Předmět:	Pegylated interferon alfa-2b medicine.medical_specialty Hepatology business.industry Internal medicine Gastroenterology medicine In patient business Peginterferon alfa-2a medicine.drug
Zdroj:	Gastroenterology. 134:A-788
ISSN:	0016-5085
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::4641c0617565a5d32ec1513de1149b4c https://doi.org/10.1016/s0016-5085(08)63680-x Zobrazit plný text záznamu